OMEGA HEALTHCARE REPORTS OFFICER/DIRECTOR CHANGES, COMP PLANS

TL;DR

**OMEGA HEALTHCARE just filed an 8-K about leadership changes and exec pay.**

AI Summary

OMEGA HEALTHCARE INVESTORS, INC. filed an 8-K on January 2, 2024, reporting an event that occurred on January 1, 2024. The filing indicates information regarding the departure or election of directors or officers, and compensatory arrangements for certain officers. This matters to investors as changes in leadership and executive compensation can signal shifts in company strategy, financial health, or governance, potentially impacting future stock performance.

Why It Matters

Changes in executive leadership and compensation structures can directly influence a company's strategic direction and operational efficiency, which are key drivers of long-term shareholder value.

Risk Assessment

Risk Level: low — This 8-K is a routine disclosure of corporate governance changes, not an announcement of adverse financial events.

Analyst Insight

Investors should monitor subsequent filings or company announcements for specific details regarding the changes in directors/officers and compensatory arrangements to understand their potential impact on the company's future strategy and financial health.

Key Players & Entities

• OMEGA HEALTHCARE INVESTORS, INC. (company) — the registrant filing the 8-K
• January 1, 2024 (date) — date of the earliest event reported
• January 2, 2024 (date) — date the 8-K was filed
• Maryland (company) — state of incorporation for OMEGA HEALTHCARE INVESTORS, INC.

FAQ

From the Filing

0001104659-24-000116.txt : 20240102 0001104659-24-000116.hdr.sgml : 20240102 20240102080039 ACCESSION NUMBER: 0001104659-24-000116 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20240101 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240102 DATE AS OF CHANGE: 20240102 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMEGA HEALTHCARE INVESTORS INC CENTRAL INDEX KEY: 0000888491 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] ORGANIZATION NAME: 05 Real Estate & Construction IRS NUMBER: 383041398 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11316 FILM NUMBER: 24500285 BUSINESS ADDRESS: STREET 1: 303 INTERNATIONAL CIRCLE, STREET 2: SUITE 200 CITY: HUNT VALLEY STATE: MD ZIP: 21030 BUSINESS PHONE: 410-427-1700 MAIL ADDRESS: STREET 1: 303 INTERNATIONAL CIRCLE, STREET 2: SUITE 200 CITY: HUNT VALLEY STATE: MD ZIP: 21030 8-K 1 tm2333150d1_8k.htm FORM 8-K false 0000888491 0000888491 2024-01-01 2024-01-01 iso4217:USD xbrli:shares iso4217:USD xbrli:shares       UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549       FORM 8-K       CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported): January 1, 2024   OMEGA HEALTHCARE INVESTORS, INC. (Exact name of registrant as specified in its charter)   Maryland 1-11316 38-3041398 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)   303 International Circle , Suite 200 Hunt Valley , Maryland 21030 (Address of principal executive offices / Zip Code)   ( 410 ) 427-1700 (Registrant’s telephone number, including area code)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:     ¨ Written communications pursuant to Rule 425 under the Securities Act.     ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act.     ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.     ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company  ¨   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨   Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:   Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $.10 par value OHI New York Stock Exchange             Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.   As of January 1, 2024, Omega Healthcare Investors, Inc. (the “Company”) entered into amendments of the employment agreements with each of the Company’s named executive officers to extend the term of their respective employment agreements by one year to December 31, 2026 and to revise their annual base salaries in accordance with the annual review conducted by the Compen